This Is MS Multiple Sclerosis Knowledge & Support Community

Hey all! Happy new year everyone! I get right down to the core in my post. Ocrevus will soon probably be approved by to FDA. But how will FDA view the risks with this heavily immunosupressive agent ? Becuase there are clear risks that the sponsor Roche and it marketing division are not so happy to t...

FOR SOME REASON, many tends to underestimate the risks with Ocrelizumab ( Ocrevus ) - it is far to much blue sky (sorry) opinions aired about this, to my view, risky MS-agent. APART FROM ALL these cancer cases in the ORATORIO / PPMS trial (2.3% vs 0.8%) and also worrying 6 cases of breast cancer vs ...

I so wish that a new MS drug, preferably oral, without immunosuppression features would eventually be developed ... because we really need it. There is always a price to be paid for long term immunosuppression. So this is what I read today in a newly published paper - and it relates to all drugs tha...

I so wish that a MS drug without immunosuppression features would eventually be developed ... because we need it. There is always a price to be paid for long term immunosuppression: So this is what I read today in a newly published paper - and it relates to all drugs that have immunosuppression as a...

Thanks for comment David1949. Yes true, Ocrelizumab is an heavy immune suppressant - or heavy artillery. Now, to completely deplete all the CD-20 B cells will not be good in the long run. And as Professor Dr Mark Freedman, Neurologist in Ottawa, says in the video, it will be risky. And the Ocrelizum...

Hi! I am a new member at this page. But I have been reading this page for several years. So today I pull myself together and registered :-D It is a way to get more actively involved instead of being just passive. So then, I was diagnosed with PPMS 8 years ago. And of course I am longing for a favour...